Share

Commentary: 50 Years of the EORTC – making the difference for the European Oncology Community

Prof Françoise Meunier, Director General, EORTC

In this interview with Mark Lawler, Interlocutor – European Perspectives for The Oncologist, Prof Françoise Meunier, EORTC Director General, recounts some of the successes of the EORTC and identifies key challenges it faces in its pioneering role in the research and treatment of cancer in Europe.

Please also see the accompanying article to this video which appeared in The Oncologist.

Back to news list

Related News

  • New European AI assistant to make patient experiences actionable for care and health systems

  • First site activated in EORTC STARBURST-1, the research project on muscle-invasive bladder cancer

  • EORTC at ESMO 2026: New findings and ongoing studies

  • EORTC research presented at ESMO 2026

  • EORTC Quality of Life Group at ISOQOL 2026

  • Pink October 2026: Advancing breast cancer research, together

  • EORTC presents new results in neuro-oncology at EANO

  • In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group

  • New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults

  • New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors